ClearSign Technologies Corp [CLIR] Filings

10-Q 1 clir-20240930x10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to _______________

Commission File Number 001-35521

CLEARSIGN TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)


Delaware (State or other jurisdiction of incorporation or organization)		26-2056298 (I.R.S. Employer Identification No.)

8023 E. 63rd Place, Suite 101

Tulsa, Oklahoma 74133

(Address of principal executive offices)

(Zip Code)

(918) 236-6461

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Common Stock	CLIR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period than the registrant was required to submit such files). Yes ⌧ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐

Non-accelerated filer ⌧		Smaller reporting company ☒

		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

As of November 6, 2024, the issuer has 50,234,407 shares of common stock, par value $0.0001, issued and outstanding.

TABLE OF CONTENTS


PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements (unaudited)

	Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023	1

	Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2024 and 2023	2

	Condensed Consolidated Statements of Stockholders’ Equity for the three month periods during the nine months ended September 30, 2024 and 2023	3

	Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023	5

	Notes to Condensed Consolidated Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Conditions and Results of Operations	22

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	29

Item 4.	Controls and Procedures	29

PART II	OTHER INFORMATION	30

Item 1.	Legal Proceedings	30

Item 1A.	Risk Factors	30

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31

Item 3.	Defaults Upon Senior Securities	31

Item 4.	Mine Safety Disclosures	32

Item 5.	Other Information	32

Item 6.	Exhibits	32

	SIGNATURES	34

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Balance Sheets

(Unaudited)


(in thousands, except share and per share data)	September 30,		December 31,
	2024		2023
ASSETS

Current Assets:
Cash and cash equivalents	$	14,486	$	5,684
Accounts receivable		749		287
Contract assets		149		188
Prepaid expenses and other assets		610		350
Total current assets		15,994		6,509

Fixed assets, net		245		275
Patents and other intangible assets, net		855		836

Total Assets	$	17,094	$	7,620

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
Accounts payable and accrued liabilities	$	1,486	$	366
Current portion of lease liabilities		82		71
Accrued compensation and related taxes		401		703
Contract liabilities		174		1,116
Total current liabilities		2,143		2,256
Long Term Liabilities:
Long term lease liabilities		128		172
Total liabilities		2,271		2,428

Commitments and contingencies (Note 9)

Stockholders’ Equity:
Preferred stock, $0.0001 par value, zero shares issued and outstanding		—		—
Common stock, $0.0001 par value, 50,234,407 and 38,687,061 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively		5		4
Additional paid-in capital		112,686		98,922
Accumulated other comprehensive loss		(16)		(17)
Accumulated deficit		(97,852)		(93,717)
Total stockholders' equity		14,823		5,192

Total Liabilities and Stockholders' Equity	$	17,094	$	7,620

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)


(in thousands, except share and per share data)	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023

Revenues	$	1,859	$	85	$	3,006	$	1,129
Cost of goods sold		1,308		61		1,976		870

Gross profit		551		24		1,030		259

Operating expenses:
Research and development		329		93		1,012		440
General and administrative		1,655		1,428		4,840		4,649

Total operating expenses		1,984		1,521		5,852		5,089

Loss from operations		(1,433)		(1,497)		(4,822)		(4,830)

Other income, net
Interest income		146		85		284		237
Government assistance		131		38		395		145
Gain from sale of assets		—		—		—		5
Other income, net		1		42		8		204
Total other income, net		278		165		687		591

Net loss	$	(1,155)	$	(1,332)	$	(4,135)	$	(4,239)

Net loss per share - basic and fully diluted	$	(0.02)	$	(0.03)	$	(0.09)	$	(0.11)

Weighted average number of shares outstanding - basic and fully diluted		54,714,910		38,562,127		46,986,914		38,459,313

Comprehensive loss
Net loss	$	(1,155)	$	(1,332)	$	(4,135)	$	(4,239)
Foreign-exchange translation adjustments, net of taxes		5		(1)		1		(13)
Comprehensive loss	$	(1,150)	$	(1,333)	$	(4,134)	$	(4,252)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Stockholders’ Equity

For the Three Month Periods During the Nine Months Ended September 30, 2024 and 2023

(Unaudited)


						Accumulated Other				Total
(in thousands, except per share data)	Common Stock			Additional		Comprehensive		Accumulated		Stockholders’
	Shares	Amount		Paid-In Capital			Loss	Deficit		Equity
Balances at December 31, 2023	38,687	$	4	$	98,922	$	(17)	$	(93,717)	$	5,192
Share-based compensation	67		—		67		—		—		67
Tax withholdings related to share-based compensation	(22)		—		(16)		—		—		(16)
Fair value of stock issued in payment of accrued compensation	307		—		326		—		—		326
Shares issued for services	4		—		3		—		—		3
Foreign-exchange translation adjustment	—		—		—		(3)		—		(3)
Net loss	—		—		—		—		(1,108)		(1,108)
Balances at March 31, 2024	39,043		4		99,302		(20)		(94,825)		4,461

Share-based compensation	256		—		344		—		—		344
Tax withholdings related to share-based compensation	(11)		—		(13)		—		—		(13)
Shares issued for services	4		—		3		—		—		3
Issuance of common stock in public offering, net of expenses	5,314		1		2,390		—		—		2,391
Issuance of warrants in public offering, net of expenses	—		—		1,831		—		—		1,831
Issuance of common stock in private placement, net of expenses	2,250		—		865		—		—		865
Issuance of prefunded warrants in private placement, net of expenses	—		—		1,214		—		—		1,214
Issuance of warrants in private placement, net of expenses	—		—		2,389		—		—		2,389
Issuance of common stock for participation right exercise, net of expenses	3,350		—		1,447		—		—		1,447
Issuance of prefunded warrants for participation right exercise, net of expenses	—		—		580		—		—		580
Issuance of warrants for participation right exercise, net of expenses	—		—		2,250		—		—		2,250
Foreign-exchange translation adjustment	—		—		—		(1)		—		(1)
Net loss	—		—		—		—		(1,872)		(1,872)
Balances at June 30, 2024	50,206		5		112,602		(21)		(96,697)		15,889

Share-based compensation	—		—		73		—		—		73
Tax withholdings related to share-based compensation	—		—		(9)		—		—		(9)
Shares issued for services	29		—		20		—		—		20
Foreign-exchange translation adjustment	—		—		—		5		—		5
Net loss	—		—		—		—		(1,155)		(1,155)
Balances at September 30, 2024	50,235	$	5	$	112,686	$	(16)	$	(97,852)	$	14,823

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Stockholders’ Equity

For the Three Month Periods During the Nine Months Ended September 30, 2024 and 2023

(Unaudited)


						Accumulated Other				Total
(in thousands, except per share data)	Common Stock			Additional		Comprehensive		Accumulated		Stockholders'
	Shares	Amount		Paid-In Capital			Loss	Deficit		Equity
Balances at December 31, 2022	38,023	$	4	$	98,079	$	(8)	$	(88,523)	$	9,552
Share-based compensation	223		—		227		—		—		227
Fair value of stock issued in payment of accrued compensation	296		—		234		—		—		234
Shares issued for services ($0.66 per share)	4		—		3		—		—		3
Foreign-exchange translation adjustment	—		—		—		—		—		—
Net loss	—		—		—		—		(1,429)		(1,429)
Balances at March 31, 2023	38,546		4		98,543		(8)		(89,952)		8,587

Share-based compensation	—		—		59		—		—		59
Shares issued upon exercise of options ($0.54 per share)	12		—		—		—		—		—
Shares issued for services ($0.66 per share)	4		—		2		—		—		2
Foreign-exchange translation adjustment	—		—		—		(12)		—		(12)
Net loss	—		—		—		—		(1,478)		(1,478)
Balances at June 30, 2023	38,562		4		98,604		(20)		(91,430)		7,158

Share-based compensation	—		—		119		—		—		119
Shares issued for services ($0.66 per share)	4		—		2		—		—		2
Foreign-exchange translation adjustment	—		—		—		(1)		—		(1)
Net loss	—		—		—		—		(1,332)		(1,332)
Balances at September 30, 2023	38,566	$	4	$	98,725	$	(21)	$	(92,762)	$	5,946

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Cash Flows

(Unaudited)


(in thousands)	For the Nine Months Ended September 30,
	2024		2023
Cash flows from operating activities:
Net loss	$	(4,135)	$	(4,239)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services		26		7
Share-based compensation		484		419
Reserve for share-based compensation tax withholdings		(38)		—
Depreciation and amortization		138		231
Impairment of intangible assets		17		14
Gain from sale of fixed assets		—		(5)
Right-of-use asset amortization		64		105
Realized gain from marketable securities		—		(79)
Lease amendments		(3)		(14)
Change in operating assets and liabilities:
Contract assets		39		13
Accounts receivable		(462)		(8)
Prepaid expenses and other assets		(260)		(116)
Accounts payable, accrued liabilities, and lease liabilities		1,091		6
Accrued compensation and related taxes		23		329
Contract liabilities		(942)		1,554
Net cash used in operating activities		(3,958)		(1,783)

Cash flows from investing activities:
Acquisition of fixed assets		(18)		—
Disbursements for patents and other intangible assets		(159)		(95)
Proceeds from sale of fixed assets		—		5
Purchases of held-to-maturity short-term U.S. treasuries		—		(2,162)
Redemption of held-to-maturity short-term U.S. treasuries		—		4,847
Net cash provided by (used in) investing activities		(177)		2,595

Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs		12,967		—
Taxes paid related to vesting of restricted stock units		(31)		(15)
Net cash provided by (used in) financing activities		12,936		(15)
Effect of exchange rate changes on cash and cash equivalents		1		(13)

Net change in cash and cash equivalents		8,802		784
Cash and cash equivalents, beginning of period		5,684		6,451
Cash and cash equivalents, end of period	$	14,486	$	7,235

Supplemental disclosure of cash flow information:
Officer and employee equity awards for prior year accrued compensation	$	326	$	234
Prior year prepaid expenses repurposed to fixed assets as demonstration equipment	$	—	$	209
Non-cash impact of new lease	$	32	$	34

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

ClearSign Technologies Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 – Organization and Description of Business

ClearSign Technologies Corporation (“ClearSign” or the “Company”) designs and develops products and technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness. The Company’s patented technologies are designed to be embedded in established original equipment manufacturers (“OEM”) products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations in order to enhance the performance of combustion systems and fuel safety systems in a broad range of markets. These markets include energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. The Company’s primary technology is its ClearSign Core technology, which achieves very low emissions without the need of selective catalytic reduction.

The Company was originally incorporated in the State of Washington in 2008. During January 2022, the Company relocated its headquarters from Seattle, Washington to Tulsa, Oklahoma. Effective June 15, 2023, the Company changed its state of incorporation to Delaware. On July 28, 2017, the Company incorporated a subsidiary, ClearSign Asia Limited, in Hong Kong to represent the Company’s business and technological interests throughout Asia. Through ClearSign Asia Limited, the Company has established a wholly foreign owned enterprise (“WFOE”) in China – ClearSign Combustion (Beijing) Environmental Technologies Co., LTD. On August 22, 2024, the Company’s Board of Directors (the “Board”) authorized management to move forward with filing for dormancy with Chinese regulators to suspend the Company’s Beijing, China operations. A dormancy filing allows the Company to keep its China legal entity in a suspended status for up to three years. The Company can revive its China operations at any time during those three years with minimal cost impact. Based on the Company’s current project plans, it expects to file for dormancy on or near December 31, 2024.

Unless otherwise stated or the context otherwise requires, the terms “we,” “us,” “our,” “ClearSign” and the “Company” refer to ClearSign Technologies Corporation and its subsidiary, ClearSign Asia Limited.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2023 has been derived from the Company’s audited consolidated financial statements as of that date.

In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.

The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

Liquidity

The Annual Report on Form 10-K filed with the SEC on April 1, 2024, contained a “going concern” note, which raised substantial doubt about our ability to continue as a going concern. We believe that we have alleviated the substantial doubt by selling equity securities on April 23, 2024, May 15, 2024, and June 24, 2024, which resulted in aggregate gross proceeds of approximately $14.2 million and net proceeds of approximately $13.0 million, after broker discounts and related fees. Refer to “Note 7 – Equity” for further details about the offerings effectuated during the nine months ended September 30, 2024.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Research and Development

The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share-based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and development costs have been offset by funds received, if any, from strategic partners in cost sharing, collaborative projects. During the three and nine months ended September 30, 2024, the Company received $28 thousand and $135 thousand, respectively, from these arrangements. During the three and nine months ended September 30, 2023, the Company received $60 thousand from these arrangements.

Foreign Operations

The accompanying unaudited condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023 include assets amounting to approximately $209 thousand and $334 thousand, respectively, relating to the operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by June 30, 2032, and of which $211 thousand has been paid as of September 30, 2024. On August 22, 2024, the Board authorized management to move forward with filing for dormancy with Chinese regulators to suspend the Company’s Beijing, China operations. A dormancy filing allows the Company to keep its China legal entity in a suspended status for up to three years. The Company can revive its China operations at any time during those three years with minimal cost impact. Based on the Company’s current project plans, it expects to file for dormancy on or near December 31, 2024. We will incur one-time non-recurring costs related to this project for severance and related benefit costs, equipment disposal and shipment costs, and legal filing fees. During the three months ended September 30, 2024, we recorded a one-time non-recurring $394 thousand accrual estimate related to our decision to suspend our China operations.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 requires expanded disclosures about reportable segments including additional information on segment expenses, expanded interim period disclosures, and an explanation of how the chief operating decision maker utilizes segment information in evaluating segment performance. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We are currently assessing the impact that the adoption of ASU 2023-07 will have on the disclosures in our consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). The FASB issued ASU 2023-09 to enhance the transparency and decision-making usefulness of income tax disclosures by requiring additional information on an entity's tax rate reconciliation, as well as

income taxes paid. ASU 2023-09 is effective for our reporting period beginning January 1, 2025. We are currently assessing the impact that the adoption of ASU 2023-09 will have on the disclosures in our consolidated financial statements.

Note 3 – Fixed Assets

Fixed Assets

Fixed assets are summarized as follows:


	September 30,		December 31,
(in thousands)	2024		2023
Office furniture and equipment	$	78	$	60
Leasehold improvements		43		43
		121		103
Accumulated depreciation and amortization		(80)		(63)
		41		40
Operating lease ROU assets, net		204		235
Total	$	245	$	275

Depreciation expense for the three and nine months ended September 30, 2024 was $4 thousand and $15 thousand, respectively.

Depreciation expense for the three and nine months ended September 30, 2023 was $41 thousand and $122 thousand, respectively.

Leases

The Company leases office space in Tulsa, Oklahoma, Seattle, Washington, and Beijing, China. During the nine months ended September 30, 2024 and 2023, the Company renewed its Beijing, China lease for 13 months with monthly rent at approximately $3 thousand. As a result of these renewals, the Company increased the right-of-use (“ROU”) asset and lease liability by $32 thousand and $34 thousand during the nine months ended September 30, 2024 and 2023, respectively.

The Company exited our long term Seattle operating lease on September 30, 2023. During October 2023, the Company entered into a sub-lease agreement to rent office space in Seattle for approximately $2 thousand per month for twelve months. We renewed the twelve month Seattle sub-lease during October 2024 with substantially the same terms. The Tulsa and Beijing leases are classified as operating leases, with remaining terms ranging from less than twelve months to approximately four years; contractual language requires renewal negotiations to occur at or near termination. These leases are normal and customary for office space, in that, contractual guarantees exist requiring the lessee return the premises to its original functional state. The Company did not incur restoration expenses for the three and nine months ended September 30, 2024. The Company did not incur restoration expenses for the three months ended September 30, 2023, and incurred $31 thousand for the nine months ended September 30, 2023.

The Tulsa lease contains fixed annual lease payments that increase annually by 2%. The Seattle, Tulsa, and Beijing total monthly minimum rent is approximately $10 thousand. Operating lease costs for the three and nine months ended September 30, 2024 were $25 thousand and $73 thousand, respectively. Operating lease costs for the three and nine months ended September 30, 2023 were $35 thousand and $117 thousand, respectively.

Supplemental balance sheet information related to operating leases is as follows:


		September 30,			December 31,
(in thousands)		2024			2023
Operating lease ROU assets, net	$	204		$	235
Lease Liabilities:
Current lease liabilities	$	82		$	71
Long term lease liabilities		128			172
Total lease liabilities	$	210		$	243

Weighted average remaining lease term (in years):		2.7			2.4
Weighted average discount rate:		5.3	%		5.2	%

Supplemental cash flow information related to operating leases is as follows:


	For the Nine Months Ended
	September 30,
(in thousands)		2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in operating leases	$	73	$	134
Non-cash impact of new leases and lease modifications
Change in operating lease liabilities	$	29	$	25
Change in operating lease ROU assets	$	32	$	39

Minimum future payments under the Company’s operating lease liabilities as of September 30, 2024 are as follows:


	Discounted		Payments
	lease		due under
(in thousands)	liability		lease
	payments		agreements
2024 (remaining 3 months)	$	22	$	24
2025		75		82
2026		63		67
2027		50		52
Total	$	210	$	225

At September 30, 2024, $15 thousand of our future minimum lease payments represents interest.

Note 4 – Patents and Other Intangible Assets

Patents and other intangible assets are summarized as follows:


	September 30,		December 31,
(in thousands)	2024		2023
Patents
Patents pending	$	351	$	477
Issued patents		1,011		810
		1,362		1,287
Trademarks
Trademarks pending		—		4
Registered trademarks		86		86
		86		90
Other		8		8
		1,456		1,385
Accumulated amortization		(601)		(549)
	$	855

ClearSign Technologies Corp [CLIR] Filings
10-Q	[2024-11-14]
10-Q	[2024-08-14]
S-1	[2024-05-20]
10-Q	[2024-05-15]
10-K	[2024-04-01]
10-Q	[2023-11-14]
10-Q	[2023-08-14]
10-Q	[2023-05-15]
10-K	[2023-03-31]
10-Q	[2022-11-14]
10-Q	[2022-08-15]
10-Q	[2022-05-16]
10-K	[2022-03-31]
10-Q	[2021-11-12]
10-Q	[2021-08-20]
10-Q	[2021-05-17]
10-K	[2021-03-31]
10-Q	[2020-11-13]
10-Q	[2020-08-14]
10-Q	[2020-05-14]
10-K	[2020-03-30]
10-Q	[2019-11-13]
10-Q	[2019-08-14]
10-Q	[2019-05-14]
10-K	[2019-03-12]
10-Q	[2018-11-08]
10-Q	[2018-08-13]
10-Q	[2018-05-10]
10-K	[2018-03-27]
10-Q	[2017-11-09]
S-1	[2017-11-09]
10-Q	[2017-08-14]
10-Q	[2017-05-11]
10-K	[2017-02-14]
10-Q	[2016-11-14]
10-Q	[2016-08-11]
10-Q	[2016-05-12]
10-K	[2016-03-03]
10-Q	[2015-11-12]
10-Q	[2015-08-13]
10-Q	[2015-05-14]
10-K	[2015-02-26]
10-Q	[2014-11-13]
10-Q	[2014-08-12]
10-Q	[2014-05-08]
10-K	[2014-03-11]
10-Q	[2013-11-12]
10-Q	[2013-08-14]
10-Q	[2013-05-06]
10-K	[2013-02-22]
10-Q	[2012-11-08]
10-Q	[2012-08-06]
10-Q	[2012-06-11]